Abstract

With diabetes mellitus as the fourth leading cause of disease-related death in the US, it is no surprise that companies are stepping up research efforts to try to combat this condition. In the US, 20 products are currently in clinical trials for the treatment of diabetes and its associated complications, according to a report by the US Pharmaceutical Manufacturers’ Association.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.